Symphony's R&D Project Delivers Accessible Medications for Telangana

Symphony Pharma Lifesciences Pvt. Ltd.'s upcoming Research and Development Center project in Kolthur, nestled within the Genome Valley at Biotech Park Phase-II, stands poised to revolutionize pharmaceutical innovation. This cutting-edge facility, anticipated to have a monthly capacity of 10 Tons Per Month (TPM), focuses on providing tailored research and manufacturing services for the pharmaceutical domain. Their scope spans chemistry support for drug discovery, clinical drug substance manufacturing for preclinical studies, generic API process development, and analytical method validations.

This initiative's key features spotlight a state-of-the-art facility equipped with advanced technology to facilitate robust research and development. The team, comprising seasoned scientists and marketing professionals, aims to drive innovation by addressing unmet medical needs and offering bespoke solutions to clients. Emphasizing a client-centric approach, Symphony Pharma Lifesciences commits to tailored services aligned with specific client requisites.

While the project is likely in the early phases, an official completion timeline is pending. However, the envisioned capacity of 10 TPM positions this R&D center to significantly impact pharmaceutical research and development in India. Beyond its potential to innovate, this initiative holds promise in generating employment opportunities and catalyzing the development of novel drugs, fostering growth within the pharmaceutical landscape.

As on January, 2024. The project has begun the stage of receiving approvals. Clearances were obtained for the project. Work on the project is scheduled to begin in March of 2024.

News by Rahul Yelligetti